Danish Biotech Stock News

Rockwool (CPSE:ROCK B) has been drawing attention after a mixed run in its stock performance, with the share price up over the past month but down over the past 3 months and year. See our latest analysis for Rockwool. At a share price of DKK194.8, Rockwool’s recent 1 month share price return of 2.47% contrasts with a 1 year total shareholder return that declined 34.22%. This suggests recent momentum is improving after a weaker period. If Rockwool’s recent moves have you thinking about where...

TCM Group (CPSE:TCM) opened 2026 with Q1 revenue of DKK362.4 million and basic EPS of DKK1.45, setting the tone for how investors will read the latest numbers against the stock’s current price of DKK71.8. The company has seen quarterly revenue move from DKK308.1 million in Q1 2025 to DKK362.4 million in Q1 2026, while basic EPS shifted from DKK1.16 to DKK1.45 over the same period. Trailing twelve month EPS stands at DKK7.83 on revenue of DKK1,333.5 million, which puts the focus squarely on...

Last week, you might have seen that Matas A/S ( CPH:MATAS ) released its annual result to the market. The early...

Scandinavian Tobacco Group (CPSE:STG) has opened Q1 2026 with a recent quarterly run rate of DKK2,343.3 million in revenue and basic EPS of DKK2.1, set against a trailing 12 month revenue base that has moved from DKK9,202.1 million to DKK9,035.7 million while TTM EPS has shifted from DKK11.45 to DKK8.50. Over the same window, trailing net income excluding extra items has gone from DKK939.7 million to DKK669.4 million. The latest release therefore lands in a context where margins and earnings...

As the pan-European STOXX Europe 600 Index recently experienced a decline, driven by geopolitical tensions and inflationary concerns, investors are increasingly looking towards small-cap stocks for potential growth opportunities. In this environment, identifying companies with robust earnings growth and resilience to economic pressures can be key to enhancing an investment portfolio.

Novo Nordisk (CPSE:NOVO B) has transferred global rights to its clinical-stage allogeneic cell therapy for Parkinson's disease to Cellular Intelligence. The agreement includes an equity investment by Novo Nordisk, with the company also eligible for potential milestones and royalties. The Parkinson's program holds FDA Fast Track Designation, and Cellular Intelligence plans to apply AI tools to support clinical development and manufacturing. Novo Nordisk, traded as CPSE:NOVO B, is best known...

Matas (CPSE:MATAS) has wrapped up FY 2026 with Q4 revenue of DKK 1.98b and a reported loss of DKK 31m, while Basic EPS for the quarter came in at a loss of DKK 0.83. Over the past six reported quarters, revenue has ranged from DKK 1.88b to DKK 2.78b, with Basic EPS moving between a loss of DKK 0.08 and a profit of DKK 7.52 on a trailing twelve month basis, which currently stands at DKK 6.44. With trailing net margin at 2.8% versus 3.4% a year earlier, this set of results places profitability...

Q1 2026 results snapshot UIE (CPSE:UIE) has kicked off Q1 2026 with revenue of US$162.1 million and a reported loss per share of US$0.87, as net income excluding extra items came in at a loss of US$26.6 million. The company has seen revenue move from US$116.7 million in Q1 2025 to US$162.1 million in Q1 2026. Trailing twelve month EPS across the last reported periods ranged from US$2.37 to US$4.48 before settling at US$2.71 in Q1 2026, which puts the spotlight firmly on how sustainable its...

ISS (CPSE:ISS) has upgraded its 2026 outlook, flagging organic growth above 6% and an operating margin around 5.25%. The company has also expanded its share buyback programme to DKK 3.1 billion. See our latest analysis for ISS. The upgraded outlook, settlement with Deutsche Telekom and larger buyback programme have coincided with firm share price momentum, with a 30 day share price return of 12.36% and a 1 year total shareholder return of 64.03% suggesting improving sentiment over both...

Shareholders appeared unconcerned with Coloplast A/S' ( CPH:COLO B ) lackluster earnings report last week. Our analysis...

Rockwool (CPSE:ROCK B) has opened 2026 with Q1 revenue of €907 million and basic EPS of €0.40, setting the tone for investors assessing how the business is trading after a volatile 2025. Over recent quarters, revenue has held in a tight band between €907 million and €988 million, while quarterly EPS has moved between a profit of €0.60 and a loss of €1.79, capturing the swings that also pulled trailing 12 month EPS down to €0.02 on revenue of €3.9 billion. With a trailing net profit margin of...

Recent share performance and business context Novo Nordisk (CPSE:NOVO B) has drawn attention after recent price moves, with the stock up about 10.4% over the past month but down roughly 7.6% over the past 3 months. For context, the company reports annual revenue of DKK 327,800.0m and net income of DKK 121,957.0m, primarily from its Diabetes and Obesity Care segment, which accounts for DKK 307,350.0m of revenue. See our latest analysis for Novo Nordisk. At a share price of DKK287.5, Novo...

Recent performance snapshot for A.P. Møller Mærsk (CPSE:MAERSK B) A.P. Møller Mærsk (CPSE:MAERSK B) has seen mixed share performance recently, with the stock up 0.5% on the day and 4.8% over the past week, but down 3.3% over the past month. See our latest analysis for A.P. Møller - Mærsk. Looking beyond the recent pullback over the past month, the share price is roughly flat year to date while the 1 year total shareholder return of 18.8% points to stronger longer term momentum. If you are...

As Europe's major indices experience a downturn amid rising geopolitical tensions and inflationary pressures, investors are seeking opportunities in less conventional areas of the market. Penny stocks, often associated with smaller or newer companies, remain an intriguing option despite their somewhat outdated moniker. These stocks can offer growth potential at lower price points when backed by strong financials and solid fundamentals.

First quarter earnings and guidance keep focus on Netcompany Group Netcompany Group (CPSE:NETC) drew fresh attention after reporting first quarter 2026 earnings, with sales of DKK 2,413.9 million and net income of DKK 143.7 million. The company also kept its full year 2026 revenue growth targets unchanged. See our latest analysis for Netcompany Group. The first quarter results and confirmed 2026 guidance came alongside a sharp 1-day share price return of 5.68% to DKK342.6, although the 30-day...

NKT (CPSE:NKT) has just reported first quarter earnings, with sales of €864 million and net income of €61 million, together with fresh project wins in Denmark and a new product launch in North America. See our latest analysis for NKT. The earnings beat and recent contract wins seem to be feeding into strong momentum, with the share price at DKK1,056 after a 30-day share price return of 13.30% and a one year total shareholder return of 106.65%. If the power grid theme interests you, now could...

As European markets navigate geopolitical tensions and inflationary pressures, the pan-European STOXX Europe 600 Index recently experienced a slight decline, reflecting broader economic challenges. In this environment, dividend stocks can offer investors a potential source of income and stability by providing regular payouts even when market conditions are uncertain.

The subdued market reaction suggests that Solar A/S' ( CPH:SOLAR B ) recent earnings didn't contain any surprises. We...

FLSmidth (CPSE:FLS) recently reported first quarter 2026 results that combined lower sales of DKK 3,279 million with sharply higher profitability, including net income of DKK 985 million and basic earnings per share of DKK 18.1. See our latest analysis for FLSmidth. Despite the strong first quarter earnings report and recent contract wins in iron ore beneficiation, FLSmidth’s share price is down 15.7% over the past month and 22.2% over the past quarter. Its 1 year total shareholder return of...

If you are wondering whether TORM's current share price still offers value, you are not alone. This article focuses squarely on what the numbers say about the stock. TORM's stock has seen mixed short term moves, declining 1.6% over the last week but up 9.0% over the last month, while the longer term picture shows a 69.2% return year to date and 96.4% over the last year. Recent attention on TORM has been driven by ongoing interest in the energy and shipping sectors, with investors looking...

If you have been wondering whether A.P. Møller - Mærsk is priced fairly or if the market is missing something, the current setup makes the valuation question especially relevant. The stock last closed at DKK 14,695, with returns of 4.0% over the past week, a decline of 6.6% over the past month, flat performance year to date, and gains of 17.8% over 1 year, 54.1% over 3 years and 66.1% over 5 years. This gives you a mixed picture of recent momentum and longer term performance. Recent news...

Profitability pressure and dividend decision in focus Coloplast (CPSE:COLO B) has drawn fresh attention after reporting second quarter and half year results that combined higher sales with a quarterly net loss, while still confirming an interim dividend payout. See our latest analysis for Coloplast. The latest quarterly loss and lower six month net income appear to have weighed on sentiment, with the share price at DKK399.3 and a year to date share price return down 25.56%. The 5 year total...

Earlier this week, Novo Nordisk presented new sub-analyses from its OASIS 4 and STEP UP phase 3 trials at ECO 2026, showing that both oral and high-dose injectable Wegovy produced substantial weight loss and functional improvements in adults with obesity, with safety consistent with the GLP-1 class. The data also indicated that early responders can achieve very large weight reductions, most of the lost weight comes from fat rather than muscle, and oral Wegovy outperformed rival orforglipron...

Dampskibsselskabet Norden (CPSE:DNORD) has drawn attention after reporting Q1 2026 earnings, with sales of US$813.5 million and a sharp drop in net income to US$11.2 million versus US$32.5 million a year earlier. See our latest analysis for Dampskibsselskabet Norden. The Q1 2026 earnings release and the recent ex dividend date have come alongside firm share price momentum, with a 1 month share price return of 12.83% and a 1 year total shareholder return of 60.52%. This suggests recent...